Logo image of CMD

Cantel Medical (CMD) Stock Price, Quote, News and Overview

NYSEARCA:CMD - NYSE Arca -

80.37  -0.96 (-1.18%)

After market: 80.37 0 (0%)

CMD Quote, Performance and Key Statistics

Cantel Medical

NYSEARCA:CMD (6/1/2021, 8:24:59 PM)

After market: 80.37 0 (0%)

80.37

-0.96 (-1.18%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High89.76
52 Week Low39.4
Market Cap3.58B
Shares44.51M
Float28.11M
Yearly Dividend0.11
Dividend Yield0.13%
PE48.42
Fwd PE25.61
Earnings (Next)N/A N/A
IPO03-24 1980-03-24


CMD short term performance overview.The bars show the price performance of CMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20

CMD long term performance overview.The bars show the price performance of CMD in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of CMD is 80.37 null. In the past month the price decreased by -9.48%. In the past year, price increased by 60.13%.

Cantel Medical / CMD Daily stock chart

CMD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.89 234.01B
ISRG INTUITIVE SURGICAL INC 80.74 211.07B
BSX BOSTON SCIENTIFIC CORP 41.63 154.00B
SYK STRYKER CORP 31.4 145.92B
MDT MEDTRONIC PLC 16.84 115.33B
BDX BECTON DICKINSON AND CO 16.35 65.30B
EW EDWARDS LIFESCIENCES CORP 27.98 43.23B
GEHC GE HEALTHCARE TECHNOLOGY 20.29 41.62B
IDXX IDEXX LABORATORIES INC 40.25 37.07B
DXCM DEXCOM INC 53.81 34.68B
RMD RESMED INC 26.21 34.03B
PHG KONINKLIJKE PHILIPS NVR- NY 17.5 24.02B

About CMD

Company Profile

CMD logo image Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. The company is headquartered in Little Falls, New Jersey and currently employs 3,669 full-time employees. The firm's operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The firm's Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The firm's Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The firm offers a range of filters utilizing hollow fiber membrane technology.

Company Info

Cantel Medical

150 Clove Rd

Little Falls NEW JERSEY 07424 US

CEO: George L. Fotiades

Employees: 3669.0

Company Website: http://www.cantelmedical.com/

Phone: 19738907220.0

Cantel Medical / CMD FAQ

What is the stock price of Cantel Medical today?

The current stock price of CMD is 80.37 null. The price decreased by -1.18% in the last trading session.


What is the ticker symbol for Cantel Medical stock?

The exchange symbol of Cantel Medical is CMD and it is listed on the NYSE Arca exchange.


On which exchange is CMD stock listed?

CMD stock is listed on the NYSE Arca exchange.


What is the price forecast or stock price prediction for Cantel Medical stock?

4 analysts have analysed CMD and the average price target is 63.24 null. This implies a price decrease of -21.31% is expected in the next year compared to the current price of 80.37. Check the Cantel Medical stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is Cantel Medical worth?

Cantel Medical (CMD) has a market capitalization of 3.58B null. This makes CMD a Mid Cap stock.


How many employees does Cantel Medical have?

Cantel Medical (CMD) currently has 3669.0 employees.


What are the support and resistance levels for Cantel Medical (CMD) stock?

Cantel Medical (CMD) has a support level at 74.28 and a resistance level at 81.31. Check the full technical report for a detailed analysis of CMD support and resistance levels.


Is Cantel Medical (CMD) expected to grow?

The Revenue of Cantel Medical (CMD) is expected to grow by 17.48% in the next year. Check the estimates tab for more information on the CMD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy Cantel Medical (CMD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Cantel Medical (CMD) stock pay dividends?

Cantel Medical (CMD) has a dividend yield of 0.13%. The yearly dividend amount is currently 0.11. Check the full fundamental report for a detailed analysis of CMD dividend history, reliability and sustainability.


What is the Price/Earnings (PE) ratio of Cantel Medical (CMD)?

The PE ratio for Cantel Medical (CMD) is 48.42. This is based on the reported non-GAAP earnings per share of 1.66 and the current share price of 80.37 null. Check the full fundamental report for a full analysis of the valuation metrics for CMD.


CMD Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to CMD. When comparing the yearly performance of all stocks, CMD is one of the better performing stocks in the market, outperforming 70.58% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CMD Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CMD. CMD has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CMD Financial Highlights

Over the last trailing twelve months CMD reported a non-GAAP Earnings per Share(EPS) of 1.6600000000000001. The EPS decreased by -29.96% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.57%
ROA 2.56%
ROE 6.37%
Debt/Equity 0.9
Chartmill High Growth Momentum
EPS Q2Q%27.03%
Sales Q2Q%32.51%
EPS 1Y (TTM)-29.96%
Revenue 1Y (TTM)11.37%

CMD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 65% to CMD. The Buy consensus is the average rating of analysts ratings from 4 analysts.

For the next year, analysts expect an EPS growth of 82.92% and a revenue growth 17.48% for CMD


Ownership
Inst OwnersN/A
Ins Owners0.32%
Short Float %N/A
Short RatioN/A
Analysts
Analysts65
Price Target63.24 (-21.31%)
EPS Next Y82.92%
Revenue Next Year17.48%